RRML - Predictive value of expression of the CXCR4/Akt signaling pathway in the peripheral blood for brain glioma
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12


Advanced search


Top 10 downloaded articles
- May 2024 -
 
A comprehensive review of Prof... 30
Romanian Review of Laboratory ... 17
The role of nitro oxidative fa... 16
Effect of Systemic Inflammator... 16
Diagnostic value of stress myo... 15
Evaluation of routine laborato... 14
Correlations of expressions of... 13
Monitoring the sensitivity of ... 12
Evaluation of cytotoxicity and... 11
Recomandarea comună EFLM-COLA... 10

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 32(1)/2024 DOI:10.2478/rrlm-2024-0008
XML
TXT

Research article

Predictive value of expression of the CXCR4/Akt signaling pathway in the peripheral blood for brain glioma

Xueli Zou

Correspondence should be addressed to: Xueli Zou

Abstract:

Background: The aim of this study was to investigate the activation of the C-X-C chemokine receptor type 4 (CXCR4)/Akt signaling pathway in the peripheral blood of individuals diagnosed with brain glioma and assess its potential as a predictive marker. Methods: A study was carried out on 120 patients diagnosed with brain glioma who were admitted between September 2015 and October 2016 (referred to as the brain glioma group). Additionally, a control group consisting of 100 healthy individuals who underwent physical examinations during the same time frame was included. According to the postoperative follow-up results, the patients with brain glioma were divided into death subgroup (n=30) and survival subgroup (n=85). Reverse transcription-polymerase chain reaction was used to identify the presence of molecules associated with the CXCR4/Akt signaling pathway in the peripheral blood samples. Results: The expressions of the CXCR4/Akt signaling pathway-related molecules differed significantly among tumor World Health Organization (WHO) grades and clinical outcome subgroups (P<0.05). The CXCR4 expression showed a significant correlation with the WHO grade of the tumor, Akt mRNA, E-cadherin, N-cadherin, and vimentin (P<0.05). The prognosis was significantly influenced by the elevated levels of CXCR4/Akt, tumor WHO grade, E-cadherin, N-cadherin, and vimentin, which acted as autonomous risk factors. The prognostic prediction accuracy of CXCR4/Akt was 90.48% for sensitivity and 94.87% for specificity, with a significant area under the receiver operating characteristic curve of 0.908 (P<0.05). Patients with high levels of CXCR4/Akt signaling pathway-related molecules had a considerably lower 5-year survival rate compared to those with low levels (21.08% vs. 46.37%, P<0.05). Conclusions: The expression of the CXCR4/Akt signaling pathway is significantly up-regulated in the peripheral blood of patients with brain glioma and is closely related to malignant tumor transformation.

Keywords: Akt, brain glioma, Cox regression, CXCR4, Pearson

Received: 13.12.2023
Accepted: 16.1.2024
Published: 21.1.2024

 
  PDF Download full text PDF
(686 KB)
     
 
How to cite
Zou X. Predictive value of expression of the CXCR4/Akt signaling pathway in the peripheral blood for brain glioma. Rev Romana Med Lab. 2024;32(1):55-60. DOI:10.2478/rrlm-2024-0008